Key result
Among patients with atrial fibrillation who underwent successful TAVI, all-cause mortality was 8.4 per 100 patient-years, with frailty and CKD ≥ stage III identified as predictors of death.
Why the study?
To evaluate the incidence of all-cause death and identify clinical predictors of unfavorable prognosis during prospective follow-up of patients with AF undergoing TAVI.
Cohort (n=130)
No
In patients with atrial fibrillation undergoing successful TAVI, frailty and advanced chronic kidney disease are significant predictors of all-cause mortality at 1.5 years.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Staroverova et al. (2022) conducted a cohort in Atrial fibrillation in patients undergoing transcatheter aortic valve implantation (TAVI) (n=130). Clinical predictors (frailty, chronic kidney disease ≥ stage III, oncological pathology) was evaluated on All-cause mortality. Among patients with atrial fibrillation who underwent successful TAVI, all-cause mortality was 8.4 per 100 patient-years, with frailty and CKD ≥ stage III identified as predictors of death.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: